In rare flop, Merck calls it quits on Keytruda-Lynparza combo in prostate cancer aliu Tue, 03/15/2022 – 11:04
Month: March 2022
After trial flop, Exelixis drops plan to pair Cabometyx with Roche’s Tecentriq in early-stage liver cancer fkansteiner Tue, […]
A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent […]
The Otto von Guericke University Magdeburg and the Max Delbrück Center for Molecular Medicine will cooperate in the […]
Radiation therapy is one of the cornerstones of cancer therapy. However, some types of tumor respond little or […]
Sajid Javid’s suggestion that general practitioners should be employed by hospitals has caused anger by threatening the autonomy […]
We are being bullied through diktats issued by NHS England and NHS Improvement and delivered by management.1 It […]
Recently, Boris Johnson, the UK prime minister announced the government’s “Living with covid” plan. It seems to throw […]
The drug company Johnson & Johnson (J&J) has expressed regret after court documents unsealed in talcum powder litigation […]
After completing his medical training at Trinity College, Cambridge, and Barts and The London School of Medicine and […]